Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study
نویسندگان
چکیده
منابع مشابه
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
BACKGROUND Teriflunomide, a dihydro-orotate dehydrogenase inhibitor, has immunomodulatory effects, including the ability to suppress experimental allergic encephalomyelitis. In this randomized, double-blind, placebo-controlled Phase II study, the authors examined the safety and efficacy of oral teriflunomide in multiple sclerosis (MS) with relapses. METHODS Patients (n = 179) with relapsing-r...
متن کاملLoco-regional relapses from rectal cancer
Background Loco-regional relapses (LRRs) from rectal cancer still represent a major issue in colo-rectal surgery. With the introduction of Total Mesorectal Excision (TME), LRR incidence after curative resection for rectal cancer dramatically decreased from 20–40% of cases to 2–12%. Several factors are involved in predicting LRRs, the most important of these being Dukes stage. When no treatment ...
متن کاملDefining Relapses Attributed to Equine Protozoal Myeloencephalitis
Disease caused by Sarcocystis spp are associated with a variety of clinical signs including abortion, hemorrhages, hair loss, muscular disease, and neurological dysfunction. In horses, clinical disease is associated with Sarcocystis fayeri and S neurona. The genesis of and clinical progression of disease caused by these protozoans in horses is not well defined but acute, chronic, and relapsing ...
متن کاملRelapses in Patients With Giant Cell Arteritis
Giant cell arteritis (GCA) is a relapsing disease. However, the nature, chronology, therapeutic impact, and clinical consequences of relapses have been scarcely addressed. We conducted the present study to investigate the prevalence, timing, and characteristics of relapses in patients with GCA and to analyze whether a relapsing course is associated with disease-related complications, increased ...
متن کاملRelapses in patients with Henoch–Schönlein purpura
To further investigate into the relapses of Henoch-Schönlein purpura (HSP), we analyzed the frequency, clinical features, and predictors of relapses in series of 417 unselected patients from a single center. After a median follow-up of 12 (interquartile range [IQR]: 2-38) years, almost one-third of the 417 patients (n = 133; 32%; 85 men/48 women) had experienced at least 1 relapse. At the time ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology
سال: 2014
ISSN: 0340-5354,1432-1459
DOI: 10.1007/s00415-014-7395-7